These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 11737307)
1. Psammomatous malignant melanoma arising in an intradermal naevus. Monteagudo C; Ferrández A; González-Devesa M; Llombart-Bosch A Histopathology; 2001 Nov; 39(5):493-7. PubMed ID: 11737307 [TBL] [Abstract][Full Text] [Related]
2. Malignant melanoma within an intradermal nevus. Tajima Y; Nakajima T; Sugano I; Nagao K; Kondo Y Am J Dermatopathol; 1994 Jun; 16(3):301-6. PubMed ID: 7943639 [TBL] [Abstract][Full Text] [Related]
3. A metastatic melanoma with an unusual immunophenotypic profile. Gao Z; Stanek A; Chen S Am J Dermatopathol; 2007 Apr; 29(2):169-71. PubMed ID: 17414440 [TBL] [Abstract][Full Text] [Related]
4. [Contribution of monoclonal antibody HMB45 in the histopathologic diagnosis of melanoma]. Pluot M; Joundi A; Grosshans E Ann Dermatol Venereol; 1990; 117(10):691-9. PubMed ID: 1705764 [TBL] [Abstract][Full Text] [Related]
5. Desmoplastic malignant melanoma. An immunocytochemical study of 25 cases. Anstey A; Cerio R; Ramnarain N; Orchard G; Smith N; Jones EW Am J Dermatopathol; 1994 Feb; 16(1):14-22. PubMed ID: 7512798 [TBL] [Abstract][Full Text] [Related]
6. Primary intra-abdominal melanoma arising in association with extracutaneous blue naevus: a report of two cases. Shah K; Folpe AL; Miller M; Morgan JA; Raut CP; Doyle LA Histopathology; 2021 Jan; 78(2):281-289. PubMed ID: 32698251 [TBL] [Abstract][Full Text] [Related]
13. Comparison of immunohistochemical staining of the novel antibody melan-A with S100 protein and HMB-45 in malignant melanoma and melanoma variants. Blessing K; Sanders DS; Grant JJ Histopathology; 1998 Feb; 32(2):139-46. PubMed ID: 9543670 [TBL] [Abstract][Full Text] [Related]
14. A103: An anti-melan-a monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues. Jungbluth AA; Busam KJ; Gerald WL; Stockert E; Coplan KA; Iversen K; MacGregor DP; Old LJ; Chen YT Am J Surg Pathol; 1998 May; 22(5):595-602. PubMed ID: 9591730 [TBL] [Abstract][Full Text] [Related]
15. Immunoprofile of MITF, tyrosinase, melan-A, and MAGE-1 in HMB45-negative melanomas. Xu X; Chu AY; Pasha TL; Elder DE; Zhang PJ Am J Surg Pathol; 2002 Jan; 26(1):82-7. PubMed ID: 11756773 [TBL] [Abstract][Full Text] [Related]
16. Malignant melanoma derived from cerebriform intradermal naevus. Hayashi Y; Tanioka M; Taki R; Sawabe K; Kore-eda S; Utani A; Miyachi Y Clin Exp Dermatol; 2009 Dec; 34(8):e840-2. PubMed ID: 19793094 [TBL] [Abstract][Full Text] [Related]
18. Malignant amelanotic melanoma developing from an intradermal naevus in a patient with oculocutaneous albinism. Wu CY; Gao HW; Chiang CP Clin Exp Dermatol; 2009 Dec; 34(8):e590-3. PubMed ID: 19486065 [TBL] [Abstract][Full Text] [Related]
19. Psammomatous melanotic schwannoma. A new cutaneous marker for Carney's complex. Utiger CA; Headington JT Arch Dermatol; 1993 Feb; 129(2):202-4. PubMed ID: 8434979 [TBL] [Abstract][Full Text] [Related]
20. The usefulness of tyrosinase in the immunohistochemical assessment of melanocytic lesions: a comparison of the novel T311 antibody (anti-tyrosinase) with S-100, HMB45, and A103 (anti-melan-A). Clarkson KS; Sturdgess IC; Molyneux AJ J Clin Pathol; 2001 Mar; 54(3):196-200. PubMed ID: 11253130 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]